Screener
Vera Therapeutics VERA Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Vera Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Vera Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:33 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212143
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $114,351 | $354,725 |
| Marketable securities | 482,409 | 359,864 |
| Prepaid expenses and other assets, current | 19,042 | 14,294 |
| Total current assets | 615,802 | 728,883 |
| Other assets, noncurrent | 5,937 | 5,850 |
| Total assets | $621,739 | $734,733 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: |
Item 1. Financial Statements
FAQ
- What is Vera Therapeutics's total current assets?
- Vera Therapeutics (VERA) reported total current assets of $615.8M in Q1 2026.
- How has Vera Therapeutics's total current assets changed year-over-year?
- Vera Therapeutics's total current assets increased by 1.6% year-over-year, from $606.08M to $615.8M.
- What is the long-term trend for Vera Therapeutics's total current assets?
- Over 5 years (2020 to 2025), Vera Therapeutics's total current assets has grown at a 68.1% compound annual growth rate (CAGR), from $54.26M to $728.88M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Vera Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude